Flash News
Here you will find news hot from the presses! Check it monthly.
November 2011
- ISO 15189 new guidelines 2012. The VBS-GBS started an international inquiry for cooperation with our Dutch neighbour pathologists. The counterpart for BELAC in the Netherlands is CCKL which has a section dedicated to pathologists. Our Dutch colleagues made a guideline for pathology labs to get ISO 15189 accreditation ("Praktijkrichtlijn Pathologie 2004"). For 2012 and the new ISO norm a new guidance document will be made for the pathology sector. It is our goal to make this document also valid for Belgium. Will be continued...
July 2011
- invitation for a symposium to honor Prof. dr. Geubel from the Cliniques Universitaire Saint-Luc, 24th septembre at Sodehotel.
- We would like you to complete 2 small surveys:
- survey for a BELAC pathology auditor: see mailing
- survey to inquire if one
is interested in the formation of a single "Belgian
Society of Pathology": see mailing
- The year report RIZIV http://ow.ly/1ukfE0
and INAMI http://ow.ly/1ukfE0
- Screening for breastcancer works well: http://ow.ly/1ud7Fr
- Looking for accredation points for
Pathology this year? Check regularly: http://www.gbs-vbs.org/a...
- In search of accreditation points for
ethics and ecomics this year? Check: http://ow.ly/1ubb0G
- New classification lung carcinoma. BAC is
changed for AIS and invasive carcinoma. Check
free article JTO: http://ow.ly/1ua7eh
- Het eerste boek over HR beleid voor
artsen in een ziekenhuis: http://ow.ly/1u9mwd
- Dutch screening for colorectal cancer
starts in 2013: http://ow.ly/1tZZSH
June 2011
- Update and corrections in the TNM 6th and 7th edition: list of TNM corrections!
- Dr. Lars Egevad: who wants to be member of the European Network for Uro-pathology? full invitation. Imediate link to surveymonkey.
-
Nomenclature cervix cytology:
Are there any restrictions?
In negotiating this nomenclature change (cervical
cytology) there was obviously an estimate by RIZIV-INAMI
of the budgetary impact. The professional association
has an estimate of the budget change worked out based on
the following numbers:
- For the second reading (588873 -588884) a consumption
forecast of 10% of the number of benefits from 588350 to
388361
- For cytological examination in succession
(588895-588906) a consumption forecast of 10% of the
number of benefits from 588350 to 388361
- For HPV testing in screening (588932 -588943) a
consumption forecast of 7.5% in the number of
performances from 588350 to 388361
- For HPV testing in follow-up (588954-588965) a
consumption forecast of 10% of the number of benefits
from 588350 to 388361
These projections were foreseen and acceptable for the RIZIV-INAMI. It is clear
that the evolution of the budget will be followed and
consumption profiles of pathologists and laboratories
made.
Any over-consumption will certainly be tackled!
We expect therefore the sense of responsibility of our
members.
May 2011
- Honoraria may 2011: Dutch , French
- Nomenclature Pathology: include the anatomical site of every single specimen: Riziv
- Belgian Cancer Registry new statistics 2008: Dutch ; French
- HPV primary screening publication of the Dutch Health Council: HPV screening advise
- Nomenclature pathology: article 33bis molecular biology
- RIZIV new publication on quality codes for medical laboratories Riziv
- Change in article 33bis for solid tumors Riziv
- RIZIV-INAMI social stature: what do you get if you follow the convention: social stature
March 2011
- We started a twitter account that is embedded on our website to give you more rapidly news flashes. Check it regularly.
- Bosman chair VUB 2011
